Journal profile · CELL BIOLOGY
Cell Death & Disease
ISSN 2041-4889 · Springer Nature · ENGLAND · Founded 2010
Cell Death & Disease: CAS Zone 1 · Biology (2025 upgraded edition, Top journal); impact factor 12.15; fully open access; APC about USD 5,250; median 188 days to acceptance (147 articles, last 24 months); community-reported acceptance: fairly hard; 1,033 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cell Death & Disease is published by Springer Nature and is in Zone 1 of Biology in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, RNA modifications and cancer and Autophagy in Disease and Therapy, together about 24.4% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Brought to you by the editorial team of Cell Death & Differentiation, Cell Death & Disease is a peer-reviewed online journal in the field of translational cell death. It seeks to promote diverse and integrated areas of experimental and internal medicine with its specialties, including cancer, immunity and neuroscience. It is now also accepting articles in a new area: cancer metabolism. Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following: Experimental medicine Cancer Immunity Internal medicine Neuroscience Cancer metabolism
From the journal's Aims & Scope
Research area (LetPub): CELL BIOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology8.4%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology8.3%
- Autophagy in Disease and TherapyMedicine7.6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology6.6%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.5%
- Ubiquitin and proteasome pathwaysBiochemistry, Genetics and Molecular Biology5.3%
- Cell death mechanisms and regulationBiochemistry, Genetics and Molecular Biology5.2%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedPublisher website
Other: Google Scholar, Biological Abstracts, BIOSIS Previews
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 12.15LetPub ·
- Impact factor (publisher) 2025
- 12.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 11.4Publisher website ·
- CiteScore 2026-06
- 17.6LetPub ·
- SJR 2026-06
- 3.29LetPub ·
- SJR (publisher) 2025
- 3.29Publisher website ·
- SNIP 2026-06
- 2.05LetPub ·
- SNIP (publisher) 2025
- 2.05Publisher website ·
- h-index
- 85LetPub ·
- h-index
- 240OpenAlex ·
- i10-index
- 9,586OpenAlex ·
- 2-year mean citedness
- 9.43OpenAlex ·
- Self-citation rate
- 1.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 920LetPub ·
- Downloads per year (publisher) 2025
- 22,113,265Publisher website ·
Articles by year OpenAlex count · 12,362 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 936 | 936 | 762 |
| 2025 | 1,033 | 1,033 | 7,531 |
| 2024 | 933 | 933 | 19,085 |
| 2023 | 855 | 855 | 30,830 |
| 2022 | 1,049 | 1,049 | 44,158 |
| 2021 | 1,190 | 1,190 | 58,488 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
188 daysMedian, submission to acceptance · P25–P75 146 days – 242 days
- Acceptance to online
- median 15 days (147 articles)
- Submission to online
- median 205 days
- Sample
- 147 articles with submission and acceptance dates (2,194 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- Submission to acceptance
- 192 daysPublisher website ·
- Submission to publication (journal-reported)
- about 22 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 4,190 / USD 5,250 / GBP 3,550 | Yes | CC BY | |
| OpenAlex | USD 4,990 / EUR 3,990 / GBP 3,390 | — | — | |
| LetPub | GBP 3,290 / USD 4,790 / EUR 3,890 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- articleArticleLength not stated
- commentCommentLength not stated
- protocolProtocolLength not stated
- research articlesResearch articlesLength not stated
Policy excerpts from the journal's websitePublication ethics
- Publication ethics
COPE member Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2010
- ISSN
- 2041-4889
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cell Death & Disease
What CAS zone is Cell Death & Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cell Death & Disease is in Zone 1 of Biology, and in Zone 2 of the minor category Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cell Death & Disease?
The latest impact factor listed by LetPub is 12.15; CiteScore 17.6, h-index 240.
How long does peer review take at Cell Death & Disease?
Based on the dates recorded on 147 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 188 days (interquartile range 146–242 days); authors report an average review time of about 2 months; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cell Death & Disease?
According to LetPub and DOAJ records, Cell Death & Disease is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE and PubMed; that list has not been checked against each database.
Is Cell Death & Disease open access, and what is the APC?
Cell Death & Disease is a fully open-access journal. APC about USD 5,250.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .